ViviCells International, Inc. (VCII)

ViviCells International Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 1999	FY 1998	FY 1997
Period Ending	Sep 30, 2000	Dec 31, 1999	Dec 31, 1998	Dec 31, 1997
Revenue	5.09	3.77	3.53	1.81
Revenue Growth (YoY)	44.44%	6.82%	94.88%	-
Cost of Revenue	5.27	2.94	2.59	1.28
Gross Profit	1.13	1.71	1.25	0.54
Selling, General & Admin	0.84	0.89	0.6	0.75
Other Operating Expenses	-	-	-	0.01
Operating Expenses	0.86	0.92	0.67	0.82
Operating Income	0.27	0.79	0.58	-0.28
Interest Expense	-0.58	-0.51	-0.25	-0.03
EBT Excluding Unusual Items	-0.31	0.28	0.33	-0.32
Asset Writedown	-0.08	-0.06	-0.41	-
Pretax Income	-0.4	0.22	-0.08	-0.32
Income Tax Expense	0.04	0.23	0.1	-
Net Income	-0.44	-0.01	-0.18	-0.32
Net Income to Common	-0.44	-0.01	-0.18	-0.32
Free Cash Flow	-	-1.26	-1.85	-1.11
Gross Margin	22.23%	45.42%	35.37%	29.61%
Operating Margin	5.28%	20.99%	16.43%	-15.64%
Profit Margin	-8.57%	-0.38%	-5.04%	-17.50%
Free Cash Flow Margin	-	-33.39%	-52.46%	-61.16%
EBITDA	0.29	0.83	0.65	-0.23
EBITDA Margin	5.77%	21.91%	18.45%	-12.77%
D&A For EBITDA	0.03	0.03	0.07	0.05
EBIT	0.27	0.79	0.58	-0.28
EBIT Margin	5.28%	20.99%	16.43%	-15.64%
Effective Tax Rate	-	106.67%	-	-
Advertising Expenses	-	0.08	0.09	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.